Another study showed that 18-kDa propeptide domain of LOX (LOX-PP) from LOX strongly suppresses the invasive characteristics of lung and pancreatic cancer cells by targeting Bcl2 and NF-kappaB (40). This evidence concerns the gene LOX and pancreatic neoplasm.